The U.S. Food and Drug Administration said Eli Lilly’s diabetes and weight-loss drugs marketed as Zepbound and Mounjaro are ...

Compounding pharmacies are suing the Food and Drug Administration so they can keep making imitation versions of popular—and ...

People with diabetes who took diuretics and alpha blockers had a higher risk for worsening frailty compared with those who ...

Diabetes is becoming more widespread, yet receiving a diagnosis can still be scary. Expert endocrinologists share what you ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

A groundbreaking case study from China has shown that stem cell therapy could successfully treat type 1 diabetes, helping the ...

The popularity of GLP-1 weight loss drugs has soared, which had created a shortage among many of the drugs, including Eli ...

Eli Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro are no longer in shortage, the U.S. Food and Drug ...

Adults with type 2 diabetes using metformin had a slightly lower risk of dying or developing long COVID within 180 days after ...

GLP-1 RAs are being recommended on social media, raising questions about who can see the content and what the effects might ...

Diabetes is a condition in which the body cannot regular blood sugar levels Read on to know if reversing it is possible ...